JPMorgan Chase & Co. Acquires 34,354 Shares of ZimVie Inc. (NASDAQ:ZIMV)

JPMorgan Chase & Co. increased its holdings in shares of ZimVie Inc. (NASDAQ:ZIMV - Free Report) by 18.7% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 217,773 shares of the company's stock after purchasing an additional 34,354 shares during the quarter. JPMorgan Chase & Co. owned 0.79% of ZimVie worth $3,038,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of the stock. SG Americas Securities LLC raised its holdings in shares of ZimVie by 15.7% during the fourth quarter. SG Americas Securities LLC now owns 11,110 shares of the company's stock worth $155,000 after acquiring an additional 1,508 shares during the period. EMC Capital Management increased its holdings in ZimVie by 47.0% during the 4th quarter. EMC Capital Management now owns 13,802 shares of the company's stock worth $193,000 after purchasing an additional 4,414 shares in the last quarter. Principal Financial Group Inc. acquired a new stake in shares of ZimVie in the 3rd quarter valued at about $275,000. Bailard Inc. lifted its holdings in shares of ZimVie by 35.0% in the fourth quarter. Bailard Inc. now owns 21,194 shares of the company's stock valued at $296,000 after purchasing an additional 5,494 shares in the last quarter. Finally, Fox Run Management L.L.C. acquired a new position in shares of ZimVie during the fourth quarter worth about $463,000. Institutional investors own 95.63% of the company's stock.

ZimVie Stock Up 2.0 %

Shares of ZimVie stock traded up $0.18 during trading hours on Wednesday, reaching $9.38. 116,019 shares of the company's stock were exchanged, compared to its average volume of 222,623. The stock has a market cap of $261.20 million, a P/E ratio of -0.72 and a beta of 2.14. The company has a 50 day moving average of $11.31 and a two-hundred day moving average of $13.15. The company has a current ratio of 1.94, a quick ratio of 1.38 and a debt-to-equity ratio of 0.57. ZimVie Inc. has a fifty-two week low of $8.56 and a fifty-two week high of $22.40.

ZimVie (NASDAQ:ZIMV - Get Free Report) last issued its quarterly earnings results on Wednesday, February 26th. The company reported $0.27 EPS for the quarter, beating the consensus estimate of $0.25 by $0.02. The firm had revenue of $111.52 million during the quarter, compared to analysts' expectations of $113.67 million. ZimVie had a positive return on equity of 2.90% and a negative net margin of 77.31%. On average, sell-side analysts forecast that ZimVie Inc. will post 0.6 EPS for the current fiscal year.

Analysts Set New Price Targets

ZIMV has been the topic of a number of recent research reports. B. Riley assumed coverage on ZimVie in a research report on Thursday, April 10th. They issued a "buy" rating and a $16.00 target price on the stock. Needham & Company LLC reaffirmed a "hold" rating on shares of ZimVie in a research note on Wednesday, April 9th.

ZimVie Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.